A phase II study of a modified FOLFOX6 regimen as neoadjuvant chemotherapy for locally advanced gastric cancer

BACKGROUND: We evaluated the efficacy and safety of the modified FOLFOX6 (mFOLFOX6) regimen as a neoadjuvant chemotherapy in gastric cancer patients. METHODS: Seventy-three patients with T2–T4 or N+ were enroled. Preoperative chemotherapy consisted of three cycles of mFOLFOX6. The primary end points...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiang, Zhao, Lin, Liu, Hongfeng, Zhong, Dingrong, Liu, Wei, Shan, Guangliang, Dong, Fen, Gao, Weisheng, Bai, Chunmei, Li, Xiaoyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4984457/
https://www.ncbi.nlm.nih.gov/pubmed/27172250
http://dx.doi.org/10.1038/bjc.2016.126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4984457/
https://www.ncbi.nlm.nih.gov/pubmed/27172250
http://dx.doi.org/10.1038/bjc.2016.126

Ejemplares similares